Table 1.
Prasugrel (n=3123) | Clopidogrel (n=8846) | P‐Value | |
---|---|---|---|
Demographics | |||
Age, y | 57 (50–63) | 61 (53–70) | <0.001 |
Female, % | 21.5 | 30.2 | <0.001 |
BMI, kg/m2 | 29.8 (26.5–33.8) | 29.2 (25.8–33.3) | <0.001 |
Race | <0.001 | ||
White | 88.1 | 87.9 | |
Black | 7.6 | 9.3 | |
Asian | 1.8 | 1.1 | |
Other | 2.3 | 1.1 | |
Hispanic | 4.1 | 3.1 | 0.005 |
Insurance status | <0.001 | ||
Private | 68.3 | 63.3 | |
Federal/State | 14.7 | 22.6 | |
None | 17.0 | 14.1 | |
Clinical characteristics | |||
Prior MI, % | 14.6 | 21.3 | <0.001 |
Prior heart failure, % | 3.0 | 7.0 | <0.001 |
Prior PCI, % | 17.8 | 23.0 | <0.001 |
Prior CABG, % | 5.5 | 10.6 | <0.001 |
Prior stroke/TIA, % | 1.9 | 6.6 | <0.001 |
Peripheral arterial disease, % | 3.3 | 7.5 | <0.001 |
Hypertension, % | 61.5 | 68.8 | <0.001 |
Diabetes mellitus, % | 24.6 | 27.2 | 0.003 |
Dyslipidemia, % | 62.0 | 66.9 | <0.001 |
Atrial fibrillation/flutter, % | 2.9 | 5.3 | <0.001 |
Current/recent smoker | 40.7 | 37.4 | <0.001 |
Chronic lung disease | 6.6 | 11.0 | <0.001 |
Dialysis | 0.5 | 1.4 | <0.001 |
GI/GU bleeding within 6 months | 0.8 | 1.2 | 0.13 |
Home oral anticoagulation | 1.1 | 3.8 | <0.001 |
Presentation features | |||
Transfer in from acute‐care hospital | 26.1 | 43.7 | <0.001 |
STEMI | 58.6 | 49.3 | <0.001 |
Cardiac arrest on presentation | 3.6 | 2.7 | 0.02 |
Heart failure within 2 weeks | 3.6 | 7.7 | <0.001 |
Cardiogenic shock | 2.5 | 1.9 | 0.06 |
Heart rate, bpm | 77 (66–90) | 76 (65–88) | 0.02 |
Systolic blood pressure | 141 (123–160) | 139 (121–158) | 0.002 |
Creatinine clearance, mL/minb | 78.6 (64.0–95.8) | 70.6 (53.3–89.8) | <0.001 |
High predicted bleeding risk, % | 38.8 | 48.8 | <0.001 |
High predicted mortality risk, % | 36.5 | 48.1 | <0.001 |
Hospital characteristics | |||
Region (%) | <0.001 | ||
West | 16.2 | 13.7 | |
Northeast | 14.6 | 16.0 | |
Midwest | 34.8 | 39.0 | |
South | 34.3 | 31.9 | |
Surgery capability, % | 90.8 | 89.9 | 0.11 |
Teaching hospital, % | 30.6 | 44.2 | <0.001 |
Number of hospital beds, median (IQR) | 411 (316–587) | 459 (337–639) | 0.02 |
BMI indicates body mass index; CABG, coronary artery bypass graft surgery; GI, gastrointestinal; GU, genitourinary; IQR, interquartile range; MI, myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST‐elevation myocardial infarction; TIA, transient ischemic attack.
Data are expressed as percentage of patients for categorical variables, median (25th, 75th percentiles) for continuous variables.
Creatinine clearance was calculated by the Cockroft‐Gault equation among patients not receiving dialysis.